Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring U, Henzen C, Leibbrandt Y, Maier S, Miedinger D, Müller B, Scherr A, Schindler C, Stoeckli R, Viatte S, von Garnier C, Tamm M, Rutishauser J. Leuppi JD, et al. Among authors: scherr a. JAMA. 2013 Jun 5;309(21):2223-31. doi: 10.1001/jama.2013.5023. JAMA. 2013. PMID: 23695200 Clinical Trial.
Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial.
Schuetz P, Leuppi JD, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring U, Henzen C, Leibbrandt Y, Maier S, Miedinger D, Mueller B, Scherr A, Schindler C, Stoeckli R, Viatte S, von Garnier C, Tamm M, Rutishauser J. Schuetz P, et al. Among authors: scherr a. Eur J Endocrinol. 2015 Jul;173(1):19-27. doi: 10.1530/EJE-15-0182. Epub 2015 Apr 8. Eur J Endocrinol. 2015. PMID: 25855628 Clinical Trial.
The ADO index as a predictor of two-year mortality in general practice-based chronic obstructive pulmonary disease cohorts.
Abu Hussein N, Ter Riet G, Schoenenberger L, Bridevaux PO, Chhajed PN, Fitting JW, Geiser T, Jochmann A, Joos Zellweger L, Kohler M, Maier S, Miedinger D, Schafroth Török S, Scherr A, Siebeling L, Thurnheer R, Tamm M, Puhan MA, Leuppi JD. Abu Hussein N, et al. Among authors: scherr a. Respiration. 2014;88(3):208-14. doi: 10.1159/000363770. Epub 2014 Aug 7. Respiration. 2014. PMID: 25115178 Free article.
Mortality risk prediction in COPD by a prognostic biomarker panel.
Stolz D, Meyer A, Rakic J, Boeck L, Scherr A, Tamm M. Stolz D, et al. Among authors: scherr a. Eur Respir J. 2014 Dec;44(6):1557-70. doi: 10.1183/09031936.00043814. Epub 2014 Jul 17. Eur Respir J. 2014. PMID: 25034566 Free article.
Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
Baumeler L, Papakonstantinou E, Milenkovic B, Lacoma A, Louis R, Aerts JG, Welte T, Kostikas K, Blasi F, Boersma W, Torres A, Rohde GG, Boeck L, Rakic J, Scherr A, Tamm M, Stolz D. Baumeler L, et al. Among authors: scherr a. Respirology. 2016 Jul;21(5):883-90. doi: 10.1111/resp.12758. Epub 2016 Mar 11. Respirology. 2016. PMID: 26970108 Free article.
49 results